References

  1. Nau KC, Lewis WD. Multiple myeloma: diagnosis and treatment. Am Fam Physician. 2008 Oct 1;78(7):853-9. PubMed | Google Scholar

  2. Solly S. Remaks on the pathology of molities ossium with cases. Med Chir Trans. 1844;27:435-498.8. PubMed | Google Scholar

  3. Kristinsson SY, Landgren O, Dickman PW, Derolf AR, et al. Patterns of survival in multiple myeloma: a population-based study of patients diagnosed in Sweden from 1973 to 200 J Clin Oncol. 2007 May 20;25(15):1993-9. PubMed | Google Scholar

  4. Cheema PK, Zadeh S, Kukreti V, Reece D, et al. Age 40 years and under does not confer superior prognosis in patients with multiple myeloma undergoing upfront autologous stem cell transmplant. Biol Blood Marrow Transplant. 2009 Jun;15(6):686-93. PubMed | Google Scholar

  5. Kim SJ, Kim K, Do YR, Bae SH, et al. Low-dose acyclovir is effective for prevention of herpes zoster in myeloma patients treated with bortezomib: a report from the Korean Multiple Myeloma Working Party (KMMWP) Retrospective Study. Jpn J Clin Oncol. 2011 Mar;41(3):353-7. PubMed | Google Scholar

  6. Kyle RA, Gertz MA, Witzig TE. Review of 1027 patients with newly diagnosed multiple myeloma. Mayo Clin Proc. 2003; 78(1):21-33. PubMed | Google Scholar

  7. Riccardi A, Gobbi PG, Ucci G. Changing clinical presentation of multiple myeloma. Eur J Cancer. 1991; 27(11):1401-1405. PubMed | Google Scholar

  8. San Miguel JF, Gutierrez NC, Mateo G, Orfao A. Conventional diagnostics in multiple myeloma. Eur J Cancer. 2006; 42(11):1510-1519. PubMed | Google Scholar

  9. ESMO, Guidelines, Working, Group. Multiple myeloma: ESMO clinical recommandations for diagnosis, treatment and follow-up. Ann Oncol. 2007; 18(Supplement 2):ii44-ii46. PubMed | Google Scholar

  10. Greipp PR, San Miguel JF, Durie BG. International Staging System for Multiple Myeloma. J Clin Oncol. 2005; 23(15):3412-3420. PubMed | Google Scholar